Kenya, like at least ten other African states, is also interested in using the "organic" treatment introduced by the Government of Madagascar to assist patients who have contracted the Covid-19 virus.
It was Uhuru Kenyatta who confirmed Kenya's interest, with his participation in a teleconference involving 10 African heads of state.
With Kenyatta, Presidents Cyril Ramaphosa (President of South Africa and the African Union), Abdul Fatah El Sisi (Egypt), President Felix Tshisekedi (DRC), Paul Kagame (Rwanda), Ali Bongo (Gabon), Mahamadou Issoufou (Niger), Idris Derby (Chad), Boubacar Keita (Mali) and of course Andry Rajoelina (Madagascar) discussed the adoption of the organic herbal tea called Covid CVO.
During the conference they discussed in detail the effectiveness of this natural medicine developed, it seems, successfully from Madagascar to treat their patients.
The President of Madagascar, Rajoelina, had already written a Twitter post on April 20, announcing that the herbal tea created by the Ministry of Health of his country was treating patients affected by Covid-19.
The World Health Organization (WHO) however, in a statement warned against any self-medication and confirmed that no new medicine was recommended as a cure for Covid-19.
However, the results seem flattering and the Malagasy President, who chaired the meeting and presented the product to the other heads of state in the videoconference, said he was confident that he could successfully pursue this treatment.
The presidents at the end of the virtual meeting formed an Inter-African Committee delegating their ministers of Health, Transport, Finance and Agriculture to respond to the emergencies that the pandemic is creating on the African continent. The countries have established a "Covid-19 Fund" which will be part of the African Union's initiatives in the African Centers for Disease Control and Prevention. The fund is a public-private partnership that aims to raise an initial $150 million (16 billion Ksh) for immediate needs to prevent transmission and up to $400 million (52 billion Ksh) to support a sustainable medical response to the COVID-19 pandemic.
The meeting also discussed other experimental drugs to fight the deadly virus, vaccines and clinical trials that have started worldwide.
Kenyatta also denied that he was aware of the windy project that would see Kenya as a pilot country for testing the vaccine that the UK is carrying out.